Qiagen considers selling stake in $1 billion bioinformatics division – report

Qiagen Markets QIAstat-Dx to test for coronavirus

Sascha Schuermann/Getty Images News

Qiagen NV (NYSE:QGEN) is evaluating the sale of a minority stake in its bioinformatics division, which could value the business at more than $1 billion.

The diagnostic company is working with an advisor to figure out the possibility


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button